Jennifer Ach, PT, MHA

Director, Clinical Metrics and Compliance

Cotiviti

 

Jennifer Ach, PT, MHA, is an HIT innovator who believes that provider- and patient-centric clinical data surfaced at the right time allows for actionable decisions that improve outcomes. Jennifer empowers quality data users to expand the value of rigorously collected process and outcomes measure data as a catalyst for sustainable change by empowering infrastructure and clinical product teams.

Session:
W3-Q2-F - The Aftermath: How One Employer is Using Data to Address the Opioid Crisis Among its Employees

Akintunde Akinseye, MSPH

Student

Johns Hopkins School of Medicine Division of Health Science Informatics

 

Tunde is a Survey Statistician at the National Center for Health Statistics. He works on the National Hospital Ambulatory Medical Care Survey which is a probability survey that assesses ambulatory care utilization at non-federal hospitals in the United States. He has a Bachelor’s in Biochemistry from Babcock University (Nigeria), an MSPH in Microbiology and Emerging Infectious Diseases from GWU Milken Institute School of Public Health, and a Certificate in Spatial Analysis in Public Health from the JHU Bloomberg School of Public Health. He is interested in data analytics and infectious diseases as they pertain to ambulatory care and public health.

Session:
IT-Q2G - Impact and Efficacy of a Medication Price Transparency Tool

Samm Anderegg, PharmD, MS

CEO

DocStation

 

Samm Anderegg is Chief Executive Officer at DocStation, a software platform for healthcare teams, enabling pharmacists to provide value-based care to patients. After graduating with distinction from the University of Iowa College of Pharmacy, he completed post-graduate residency training and a combined Master’s degree program specializing in Health-System Pharmacy Administration at the University of Kansas. Anderegg spent two years working in oncology and ambulatory care management at Augusta University Health System in Augusta, Georgia before founding DocStation.

Session:
IT-5 - DocStation for Value-Based Pharmacy

Monali Bhosle, PhD

Director, Pharmacy Advanced Analytics

CPESN USA, Community Care of NC

 

Monali is a health economist with over ten years of experience in healthcare analytics and predictive modeling. Monali leads the pharmacy analytics team at CPESN USA with the primary focus in creating innovative risk scoring solutions and care guidance methodologies. Monali also serves as Director of Advanced Pharmacy Analytics at Community Care of North Carolina (CCNC).

Monali’s primary responsibilities include understanding the big data and implementing effective strategies using data for improving patient care. A pharmacist by background, Monali possesses a unique combination of clinical and economics background. She has worked with various datasets including, claims and EMR from various sources. At CCNC, Monali is managing the risk score models that use prescription and hospital discharge data to help providers know which patients are at risk for future admissions and drug therapy problems and when to intervene. Monali serves as an analytic expert on Pharmacy Quality Alliance’s (PQA) Research Coordinating Committee helping them to enhance their research portfolio by providing oversight of PQA’s research focus areas and recommend potential projects, funding partners, and/or sites for research/demonstration projects.

Session:
T2-B1-B - Exploring Drivers of Community Pharmacy-Level Performance on Adherence Measures

Carrie Blanchard, PharmD, MPH

Research Assistant Professor

UNC Eshelman School of Pharmacy

 

Carrie Blanchard is a research assistant professor and lead of education and research development in the Center for Medication Optimization at the University of North Carolina Eshelman School of Pharmacy. She earned her Doctor of Pharmacy from UNC and subsequently received her Masters of Public Health in Health Policy and Management from the UNC Gillings School of Global Public Health. She completed a two-year Postdoctoral Fellowship in Implementation Science at the UNC Eshelman School of Pharmacy in partnership with the National Implementation Research Network. Dr. Blanchard’s research focuses how to implement and scale effective pharmacy services in the ambulatory care and community pharmacy setting through the use of implementation science frameworks, the selection of effective implementation strategies, and the measurement of implementation outcomes of interest.

Session:
W2-B1-A - Blending Pay-for-Performance and Implementation Science to Catalyze Medication Management Service Delivery, Improve Health and Produce Value

Ted Borgstadt

CEO and Co-Founder

TrestleTree, LLC

 

Mr. Ted Borgstadt is the CEO and Co-Founder of TrestleTree, LLC,. He provides the directional, strategic and administrative oversight to secure quantifiable value and improved health results for health plans and large self-insured employers. TrestleTree’s programs – which include lifestyle coaching, disease management, a comprehensive pain management program and a unique opioid risk disruption tool – have not only significantly improved health outcomes for members but have consistently lowered health costs. Mr. Borgstadt is a founding board member of LifeSource International, a non-profit organization helping to improve the wellbeing of families through holistically-based health support services. Mr. Borgstadt is a long-time guest lecturer at the Walton Business School, University of Arkansas. TrestleTree is based in Fayetteville, Arkansas.

Session:
W4-B1-C - Improving Quality for Rural Communities At-Risk for Opioid Abuse and Addiction: A Panel Discussion with the Rural Carrier Benefit Plan

Beth Bortz, MPP

President & CEO

Virginia Center for Health Innovation

 

Beth was named the President and CEO of the Virginia Center for Health Innovation (VCHI) in March 2012. Prior to joining VCHI, she served for nine years as the Executive Director of the Medical Society of Virginia (MSV) Foundation, where she developed and led programs in health care quality improvement, medication assistance, public health awareness, and physician leadership. Ms. Bortz also served as Senior Program Officer and Deputy Director of the Virginia Health Care Foundation for seven years and as a Senior Associate Legislative Analyst for the Virginia General Assembly’s Joint Legislative Audit and Review Commission for three years.

Ms. Bortz is a 2007 graduate of LEAD Virginia and currently serves on its Board of Directors. She also serves as a public member of the Board of Directors of the American Board of Family Medicine and on the National Task Force to Reduce Low Value Healthcare. She served as Secretary of the Board of Directors of Virginia Health Information and was a founding board member of Rx Partnership, serving as Board Chair from 2006-2008. She has received several awards and recognition for her work, including: the 2014 Virginia Leader Award from LEAD Virginia, Influential Women of Virginia Award from Virginia Lawyer’s Media; Medallion Award for Community Partnership from Mutual of America; and Stettinius Award for Nonprofit Leadership from the Community Foundation representing Greater Richmond.

Ms. Bortz earned her undergraduate degree in Economics and Government and her Masters in Public Policy from the College of William and Mary.

Session:
IT-Q8 - Virginia Center for Health Innovation

Andrea Brookhart, PharmD, BCACP

Director of Clinical Programs

Kroger Health

 

Andrea Brookhart, PharmD, BCACP is the Director of Clinical Programs for Kroger Health; in her role, she oversees development and implementation of holistic, quality clinical programs focused on preventing disease, improving patient outcomes, and supporting population health. She has been with Kroger since 2012, and her primary focus areas include improving quality measure performance, medication adherence, immunizations, improving access to care, and addressing gaps in care. Dr. Brookhart is a graduate of the University of Toledo College of Pharmacy & Pharmaceutical Sciences and of Virginia Commonwealth University’s Community-based Pharmacy Residency Program. She is an active member of the American Pharmacists Association and a Board Certified Ambulatory Care Pharmacist.

Session:
IT-CPIQ-2 - Community Pharmacy Innovation in Quality (CPIQ) Awards – Community Pharmacy – Kroger Health

Susan Cantrell, RPh, CAE

Chief Executive Officer

Academy of Managed Care Pharmacy

 

Susan Cantrell currently serves as the Chief Executive Officer of the Academy of Managed Care Pharmacy (AMCP). Previously in her career, Susan was Senior Vice President and Managing Director, Americas for the Drug Information Association (DIA).

Before joining DIA, Susan was Vice President of Resources Development at the American Society of Health‐System Pharmacists (ASHP). While at ASHP, she helped launch ASHP Advantage and build ASHP’s online learning enterprise. Under her leadership, ASHP became the only pharmacy association accredited by the Accreditation Council for Continuing Medical Education as a provider of continuing medical education for physicians.

Susan is a graduate of the University of Mississippi College of Pharmacy and she completed an ASHP-accredited hospital pharmacy residency program at University of Mississippi Medical Center. She received her Certificate in Public Health from the University of North Carolina Gillings School of Public Health. A registered pharmacist and former hospital and home care pharmacy administrator, she is certified by the American Society of Association Executives as a Certified Association Executive (CAE). She is an active member and has served in several volunteer leadership positions in the American Society of Association Executives, the Academy of Managed Care Pharmacy, the American Society of Health‐System Pharmacists, and the International Pharmaceutical Federation.

Session:
TGS-2 - General Session: The Impact of COVID-19 on Quality

Katherine Capperella

Global Head Patient Engagement Leader

Janssen

 

Katherine Capperella is Global Head, Patient Engagement Leader at Janssen. In this role, Katherine leads a cross-functional team responsible for developing and driving patient engagement strategy and measuring progress over time. She and her team are focused on leading Janssen to incorporate direct patient voice early and throughout the entire product lifecycle, beginning with disease area strategies and including target product profiles, formulations, clinical trials and post-marketing activities.

Katherine has more than 20 years of experience at Johnson & Johnson in roles of increasing responsibility. Previously, Katherine served as global commercial vice president for Janssen’s Active Pharmaceutical Ingredients (API) business developing pharmaceutical ingredients for pain. Prior to that, Katherine led a cross-functional team responsible for commercial assessments of licensing and acquisition opportunities for Janssen neuroscience. Katherine began her career in women’s health and has demonstrated success in launch, turnaround and mature businesses in a variety of disease areas.

Katherine holds a Bachelor of Science in Business/Marketing from the Kelley School of Business.

Session:
FGS-3 - General Session: The Patient Perspective in Healthcare Quality

Vidya Chakravarthy, MS-HSM

Director of Population Health

Rush University Medical Center

 

Vidya Chakravarthy, MS-HSM is responsible for oversight of key population health programs including several Value Based care management programs, the Transitional Care Program, and Rush’s Transition Clinic. She has developed and standardized care management processes to be adapted across all value based contracts and collaborated to develop and design an ACO’s complex care management program. Vidya has also expanded the Transitional Care Program across the medical center and has overseen operational metrics for all the care management programs within Population Health, including monitoring quality metrics and ensuring work flows are designed to support these measures.

Vidya received her BA from the University of Michigan, Ann Arbor and her MS-HSM from Rush University. She also serves as adjunct faculty for the Health Systems Management department.

Session:
T3-Q2-E - Population Health Management: Evaluation of MTP Category Framework in an AI Driven Value-Based Care Model

Jenny Cheung, PharmD, BCACP

Clinical Pharmacist

PerformRx

 

Jenny Cheung joined PeformRx’s prior authorization team in 2013 as a Prior Authorization Pharmacist. In 2017, she transitioned to the Clinical Outcomes and Therapeutics Optimization team as a Clinical Pharmacist. Jenny’s experience in pharmacy spans multiple settings, which include retail and hospital. In Jenny’s current role, she is able to engage members and providers in PerformRx’s drug therapy management programs to identify and resolve medication therapy problems and other gaps in care, with the goal of improving health outcomes and optimizing medication regimens. Jenny graduated from Temple University School of Pharmacy with a Doctor of Pharmacy degree and is a board-certified ambulatory care pharmacist.

Session:
F1-Q1-C - Impact of a Pharmacy Benefit Manager (PBM) Clinical Program on Behavioral Health Medication Management in Children and Adolescents

Ceci Connolly

President & CEO

Alliance of Community Health Plans

 

Ceci is president and CEO of the Alliance of Community Health Plans (ACHP), the trade association for nonprofit, community health plans. Ms. Connolly is a passionate advocate for a community-based approach to health care and a strong proponent of payer-provider collaboration. Formerly a national correspondent for The Washington Post and a leader at international consulting firm PwC, Ms. Connolly provides a comprehensive perspective on the American health care system from the everyday struggles of physicians and patients to the intricacies of health care politics.

In her current role, she works with some of the most innovative executives in the health sector to provide high-quality, affordable care to all. She is a leading thinker in the disruptive forces reshaping our health system and has been a trusted adviser to c-suite executives. Well-versed in a variety of areas pertinent to business today, she is an expert on communications, leadership coaching, crisis management and the Washington regulatory process.

She is the first non-physician to receive the prestigious Mayo Clinic Plummer Society award for promoting deeper understanding of science and medicine and is a founding member of Women of Impact (WOI) for Healthcare.

Session:
TGS-2 - General Session: The Impact of COVID-19 on Quality

Laura Cranston, RPh

Chief Executive Officer

Pharmacy Quality Alliance

 

Ms. Cranston serves as the Chief Executive Officer of the Pharmacy Quality Alliance. In this role, she oversees the development of medication use measures, and works with organizations, including health plans, PBMS, community pharmacy organizations, employers and others to encourage the uptake and implementation of meaningful medication use measures into the marketplace. Prior to her current position, Ms. Cranston served as the Executive Director for the Institute for the Advancement of Community Pharmacy, as well as in independent and chain community pharmacy practice in the United States. Prior to that, she served as the Vice President of Pharmacy Affairs for National Association of Chain Drug Stores. Ms. Cranston is a pharmacy graduate of St. John’s University College of Pharmacy and Allied Health Professions and former Executive Resident of the American Society of Consultant Pharmacists.

Sessions:
WGS-1 - General Session: The Business Impact of COVID-19
TGS-2 - General Session: The Impact of COVID-19 on Quality
FGS-4 - PQA - Recap, Preview of Additional Educational Opportunities

Sarah Dean, PharmD, MPH

Clinical Program Lead, Quality Network

Humana

 

Sarah Dean is the Clinical Program Lead for Pharmacy Quality Network at Humana, where she focuses on clinical quality and Stars efforts to improve member outcomes. She leads engagement with pharmacies on clinical initiatives as well as the development and testing of initiatives to advance overall quality performance.

Session:
W1-B2-F - Tackling Social Determinants of Health by Leveraging Community Pharmacies in a National, Scalable Model

Cameron Deml

Director of Insurance Programs

National Rural Letter Carriers' Association

 

Mr. Cameron Deml is Director of Insurance Programs for the National Rural Letter Carriers’ Association and his primary responsibility includes managing the Rural Carrier Benefit Plan. Mr. Deml leads the RCBP internal teams, setting the strategic direction and overseeing partnerships with Aetna, CVS Caremark, TrestleTree and other vendor partners. Mr. Deml also leads the quality teams at RCBP; strategic initiatives include quality improvement in rural health, coordinated care management and addressing accessibility challenges for rural members. Currently, RCBP is partnering with TrestleTree-a health coaching company-to address the Opioid Crisis through a comprehensive pain management strategy and provider engagement initiatives. Prior to joining NRLCA, Mr. Deml worked at Axia Strategies, a health care consulting company focused on business development and relationship management.

Session:
W4-B1-C - Improving Quality for Rural Communities At-Risk for Opioid Abuse and Addiction: A Panel Discussion with the Rural Carrier Benefit Plan

Donna Dugan, PhD, MS

Vice President

Discern Health

 

Dr. Donna Dugan provides insight and subject matter expertise to Discern’s clients, particularly on quality measurement, health policy, and health services research topics. Discern works with stakeholders across the system to improve health and care through advising on quality-based payment and delivery models and on how to achieve success within the value-based marketplace. Before joining Discern, Donna was an independent consultant, working on projects for organizations such NCQA, NQF, and PQA. Donna also previously served as Director of Performance Measurement at NCQA, where she led the unit that developed and implemented HEDIS measures. Donna holds a doctorate in health services research and a master’s degree in Epidemiology.

Session:
W4-B1-C - Improving Quality for Rural Communities At-Risk for Opioid Abuse and Addiction: A Panel Discussion with the Rural Carrier Benefit Plan

Joel Farley, PhD

Professor

University of Minnesota College of Pharmacy

 

Dr. Farley is a Professor and Associate Department Head in the Department of Pharmaceutical Care and Health Systems at the University of Minnesota College of Pharmacy where he holds the Peters Endowed Chair in Pharmacy Practice Innovation. He received his pharmacy degree from the University of Wisconsin and his PhD in Social and Administrative Pharmacy from the University of Minnesota. Dr. Farley's has conducted and published research on the implementation of pharmacy performance metrics in the community pharmacy setting. He has previously served as a member on PQA’s measurement development team.

Session:
T2-B1-B - Exploring Drivers of Community Pharmacy-Level Performance on Adherence Measures

John A. Galdo (Jake), PharmD, MBA, BCPS, BCGP

Director, Education and Program Development

Pharmacy Quality Alliance

 

Jake Galdo is the Director of Education and Program Development for the Pharmacy Quality Alliance (PQA). He plans and implements PQA’s educational and training programs, which promote PQA’s measures and quality initiatives for medication use and medication services. From national meetings to online educational training, Jake ensures PQA’s programs are relevant and valuable for PQA members and other quality focused health care professionals. Jake also oversees PQA’s awards programs. Previously, he was Director of Performance Measurement on the PQA team.

Jake received his Doctorate of Pharmacy and completed PGY-1 Community Practice training from the University of Georgia, earned a Masters of Business Administration from Samford University, and is board certified in both pharmacotherapy and geriatrics.

Session:
TEC - Introducing PQA's eCommunity Forum
FGS-3 - General Session: The Patient Perspective in Healthcare Quality

Jim Gartner, RPh, MBA

EVP Clinical and Product Strategy

AssureCare

 

Jim Gartner currently leads Clinical and Product Strategy at AssurecCare. AssureCare is a leading clinical platform that provides pharmacy management, utilization management, and care management all in one platform. Jim has been with AssureCare over the last 1.5 years and joined after 8 years with CareSource. Jim led pharmacy over his time at CareSource and also led utilization management, quality, provider services including contracting and the provider life cycle. Jim has worked in retail, PBM, and consulting during his career. Jim’s passion is increasing the clinical services provided by the pharmacist as evidenced by the MTM program CareSource launched across all their lines of business in 2012 and it still is going today.

Session:
IT-3 - Maximizing Medication Therapy Management Technology to Extend the Reach of the Pharmacist

William Grambley, MBA

Chief Operating Officer

AllazoHealth

 

Bill is passionate about helping people get the most from their medications. As Chief Operating Officer of AllazoHealth, he is driving the organization’s growth to create disruptive improvements to adherence and patient support programs. Prior to joining AllazoHealth, he served in a variety of leadership positions at CVS Health, including time as Vice President of Strategy and Vice President of Product Management. While at CVS Health, he delivered industry-leading clinical programs, including the award-winning Pharmacy Advisor program, which drove CVS Health clients’ Medicare Star ratings to their highest levels ever.

Earlier in his life, Bill served in the US Navy before getting an MBA from Northwestern University’s Kellogg Graduate School of Management; Bill also worked for Bain and Company and EMC before he moved to CVS Health.

Session:
IT-2 - How to Use Artificial Intelligence to Improve Your Patient Engagement Programs

Mark Gregory, RPh

Director, Pharmacy Consultant, Population Health Services

Omnicell, Inc.

 

Mr. Gregory joined Omnicell in July 2014. In his current responsibilities he works with pharmacies and payers to improve their position in the market with their medication management objectives. Most recently Senior Vice President of Store Operations previously Vice President of Pharmacy and Government Relations for Kerr Drug, Inc. based in Raleigh, North Carolina. Responsibilities included all store operations, oversight of pharmacy systems and automation, managed care contracting, store support, pharmacy administration, operational policies and procedures, patient care and compliance programs, university relationships and government affairs activities. He also served as Kerr Drug’s Privacy Officer and Chairman of Kerr Drug’s PAC.

Mark Gregory graduated in 1982 from Ohio Northern University and in October 2011 was awarded a Distinguished Alumni Award.

Other pharmacy involvement include: Past President of North Carolina Association of Pharmacists, Past Chairman Executive Committee North Carolina Retail Merchants Association and Past Chair of NACDS Policy Council.

Session:
IT-4 - Leveraging Technology to Deliver Value-Based Clinical Pharmacy Interventions: Improved Adherence and Declining Costs for Patients with Chronic Conditions

Anna Hall, PharmD, BCAP

Director of Quality Services

Enhanced Medication Services

 

Anna Hall is an experienced clinical pharmacist by training and a pioneer in building MTM programs and STAR Ratings intervention programs for prominent national prescription plan sponsors. At Enhanced Medication Services, Anna oversees strategic partnerships, contracting of clinical services, and program compliance. Over the past 10 years she has worked to develop interactive training programs designed to teach technicians and pharmacists how to engage patients in medication therapy management and encourage adherence through the provision of multi-modal interventions and motivational interviewing. Anna serves in national leadership roles for both PQA and AMCP to influence MTM innovation and consensus and contributes to the national strategy to improve effectiveness of MTM programs.

Session:
IT-4 - Leveraging Technology to Deliver Value-Based Clinical Pharmacy Interventions: Improved Adherence and Declining Costs for Patients with Chronic Conditions

Bruce Japsen

Health Care Contributing Writer

Forbes

 

Bruce Japsen writes about healthcare as a senior contributor for Forbes and is the author of Inside Obamacare. Based in Chicago, he is a regular analyst on Fox Business Channel, Chicago’s WBBM Newsradio and WTTW’s Chicago Tonight public affairs program. His work has also appeared in the New York Times, Chicago Medicine. He teaches for the University of Iowa School of Journalism.

Session:
WGS-1 - General Session: The Business Impact of COVID-19

Jamie Jenkins, PhD

Senior Program Manager

Cotiviti

 

Jamie Jenkins has been working to improve healthcare performance for 20+ years. She was the executive leader of quality & operations for a large academic physician group and an operations improvement officer for a hospital system. She received her PhD contributing a career advancement project to move low wage hospital workers into sustaining healthcare careers. She is a published writer and a lifelong learner.

Session:
W3-Q2-F - The Aftermath: How One Employer is Using Data to Address the Opioid Crisis Among its Employees

Loren Kirk, PharmD

Director of Stakeholder Engagement

Pharmacy Quality Alliance

 

Loren Kirk serves as Director of Stakeholder Engagement for the Pharmacy Quality Alliance (PQA). In this role, he is responsible for engaging and expanding PQA’s diverse membership and supporting the active participation of members in performance measurement, quality improvement, and healthcare quality education and learning. Loren also leads and supports the ideation, development, implementation, and delivery of PQA member benefits, services, and programs.

Loren completed a post-graduate Executive Fellowship with the National Association of Chain Drug Stores Foundation where he collaborated with key stakeholders and PQA members on pharmacy practice advancement initiatives, professional association governance, and healthcare policy.

Loren graduated with his Bachelors of Science in Animal Science from North Carolina State University in Raleigh, NC. He earned with his Doctorate of Pharmacy from the Bill Gatton College of Pharmacy at East Tennessee State University in Johnson City, TN. Loren served in professional association leadership roles at the national, regional, and state level.

Session:
Welcome Remarks

Dorothy Loy, PharmD, MBA

Director of Clinical Performance Strategy

Walgreens Co.

 

Dorothy Loy, PharmD, MBA is Director of Clinical Performance Strategy at Walgreens Co. She leads a team responsible for the development of the adherence and clinical performance strategies across over 9000 pharmacies. Dorothy creates forward thinking strategies to execute on with plan sponsors and PBMs that help shape the future of value based contracts. She helps identify opportunities for pharmacists to further their roles in the adherence space by taking an active role in quality metric discussions that impact pharmacy as well as helping design innovative programs that allow pharmacists to practice at the top of their license. Dorothy harnesses the strengths of partnerships by collaborating with the health plans, PBMs, health care organizations, patient advocacy groups, charity organizations, providers, pharmaceutical manufacturers and government teams to drive meaningful business value and to improve patient care outcomes.

Dorothy has over 13+ years of experience in pharmacy. She began her career as a retail pharmacist before moving to Walgreens corporate headquarters where she has held various leadership roles in several divisions including clinical, technology, innovation and strategy. Dorothy earned a PharmD from Drake University School of Pharmacy and an MBA from Drake University School of Business.

Session:
T4-B2-E - Turning Headwinds to Tailwinds: Leveraging Partnerships in a Rapidly Changing Environment to Deliver Omnichannel Programs that Deliver Higher Quality Ratings

Dani Markus, PharmD, MBA

Vice President of Quality

OutcomesMTM

 

Dr. Markus focuses on quality and innovation for OutcomesMTM. She oversees clinical initiatives including the Targeted Intervention Program (TIP®) and new MTM services. Dani leads product development to drive MTM innovation, advance program efficiency, and enhance the Connect™ Platform. She also serves the roles of Compliance and Privacy Officer. Dani currently facilitates the National MTM Advisory Board and has served on industry workgroups, including various PQA workgroups and the AMCP MTM Advisory Group.

In her tenure at OutcomesMTM, Dani has guided updates to the Insight™ Clinical Engine, served as a clinical advisor to OutcomesMTM clients, and contributed to internal workgroups aimed at driving performance within the company’s Personal Pharmacist™ Network. Dani earned her PharmD and MBA from Drake University and completed her residency with OutcomesMTM.

Session:
W1-B2-F - Tackling Social Determinants of Health by Leveraging Community Pharmacies in a National, Scalable Model

Benjamin McNabb, PharmD

Owner

Love Oak Pharmacy

 

Dr. Ben McNabb is a community pharmacist and the owner of Love Oak Pharmacy in Eastland, TX. In 2018, Ben was awarded the Outstanding Adherence Practitioner Award by the National Community Pharmacists Association for his work using adherence packaging and other medication adherence techniques to improve patient outcomes.
Additionally, Ben serves as Lead Luminary of CPESN Texas, a clinically integrated network of community-based pharmacy care providers, and as an appointed member to the Texas HHSC Value-Based Payment & Quality Improvement Advisory Committee. Ben enjoys communicating the untapped potential of community pharmacy and developing innovative payment models that improve patient outcomes and lower healthcare costs.
Ben earned his Doctor of Pharmacy from The University of Texas at Austin College of Pharmacy.

Session:
WGS-1 - General Session: The Business Impact of COVID-19

Jessie Merrey, PharmD, MBA

Clinical Pharmacy Specialist

The Johns Hopkins Hospital

 

Dr. Jessica W. Merrey is Clinical Pharmacy Specialist in Ambulatory Care at The Johns Hopkins Hospital, with practice sites at Johns Hopkins Community Physicians and Johns Hopkins Outpatient Clinic. At these clinic sites she provides patient-centered care to improve the management of chronic disease states, and serve as a drug information resource. She received her Doctorate of Pharmacy at The Medical University of South Carolina and Masters in Business Administration from the Citadel, both in Charleston, South Carolina. Dr. Merrey is Board Certified in Pharmacotherapy, Ambulatory Care, and Geriatric Pharmacy, and serves on the BPS Geriatric Specialty Council. Dr. Merrey is currently invested in researching the accuracy of price transparency tools and the impact on patient access and adherence to medications.

Session:
IT-Q2G - Impact and Efficacy of a Medication Price Transparency Tool

Klodiana Myftari, PharmD, BCACP

Assistant Professor of Pharmacy Practice

Midwestern University

 

Klodiana Myftari, PharmD, BCACP is an Assistant Professor of Pharmacy Practice at Midwestern University, Chicago College of Pharmacy. She received Doctor of Pharmacy degree and completed PGY1 residency with focus on community pharmacy from University of Illinois at Chicago, College of Pharmacy. Dr Myftari has over a decade of experience in implementation of pharmacists’ services in community pharmacy, ambulatory care and population health management.
She currently practices at Rush University Medical Center as clinical pharmacist with the Department of Population Health. She is leading the implementation and evaluation of pharmacist services in population health management via digital medicine, telehealth and traditional face to face practice models. Dr. Myftari is an active member in state and national organizations. She is the Midwestern University representative with PQA.

Session:
T3-Q2-E - Population Health Management: Evaluation of MTP Category Framework in an AI Driven Value-Based Care Model

Binal Patel, Mpharm, BCGP

Director, Clinical Outcomes & Therapeutic Optimization

PerformRx

 

Binal Patel joined PerformRx’s Clinical Outcomes and Therapeutic Optimization team in 2013 as a Clinical Pharmacist. Her experience in pharmacy spans multiple settings, including hospital, retail, and long-term care. In her current role as Director, Binal uses her expertise in MTM to develop programs that optimize medication regimens, improve health outcomes, and increase quality measures scores. She is involved in training the next generation of pharmacists through PerformRx’s MTM advanced pharmacy practice experience rotation. Binal is a member of PerformRx’s Clinical Services Advisory Team, which has oversight of PerformRx’s clinical programs. Binal graduated from University of Toronto with a bachelor’s degree in human biology. She received her Master of Pharmacy degree, with First- Class Honors, from University College London, School of Pharmacy. She is a board-certified geriatric pharmacist.

Session:
F1-Q1-C - Impact of a Pharmacy Benefit Manager (PBM) Clinical Program on Behavioral Health Medication Management in Children and Adolescents

Sapna Patel, RPh

Director of Clinical Services

Mosaic Pharmacy Services

 

Ms. Patel is Director of Clinical Services at Mosaic Pharmacy Services, where she oversees the development and delivery of clinical services for patients based at home and in long-term care communities. Prior to Mosaic, Ms. Patel was Director of Clinical Services for Advanced Patient Care where she provided much-needed pharmacist driven care-coordination. Combining medication delivery and continued clinical follow up resulted in increased adherence and reduced hospital readmissions.

Prior to Advanced Patient Care, Ms. Patel was Executive Director of Progress Pharmacy, another long-term care pharmacy. She led a team of 10 pharmacists and 20 technicians that served 35 assisted living facilities and 6 skilled nursing facilities. Ms. Patel holds a Bachelor of Science from University of the Sciences.

Session:
IT-1 Caring for Medically Complex and Vulnerable Members: The Role of a Comprehensive Pharmacy Service

Sujith Ramachandran, PhD

Assistant Professor

University of Mississippi School of Pharmacy

 

Sujith Ramachandran, PhD, is an Assistant Professor of Pharmacy Administration and an Assistant Director for the Center for Pharmaceutical Marketing & Management at the University of Mississippi School of Pharmacy. His research interests are in the area of health outcomes, healthcare quality, and prescription drug abuse. He has extensive experience with administrative claims data from Medicare and Medicaid, and a background in psychometrics and conjoint analytic techniques. He teaches doctoral courses on data management, patient-reported outcomes, and pharmacoepidemiology. He is a recipient of AACP’s 2019 New Investigator Award and has received funding from the National Institutes of Drug Abuse, and other governmental, commercial, and non-profit organizations for his research.

Session:
F2-Q1-B - Quality Measurement in Screening and Management of Osteoporosis Among Older Adults

Dan Rehrauer, PharmD

Senior Manager, MTM Program and Community Pharmacy Partnerships

HealthPartners

 

Dan Rehrauer is Senior Manager of the Medication Therapy Management Program and Community Pharmacy Partnerships at HealthPartners. Dan is an active member within PQA, serving as a Co-Chair of the Quality Metrics Expert Panel, having Co-chaired the Measure Update Panel, and participating in various measure development teams and advisory panels.

Session:
W2-B1-A - Blending Pay-for-Performance and Implementation Science to Catalyze Medication Management Service Delivery, Improve Health and Produce Value

Todd Sega, PharmD

Senior Vice President, Development and Strategy

Pharmacy Quality Solutions

 

Todd Sega, PharmD is Senior Vice President, Development & Strategy for Pharmacy Quality Solutions (PQS). In this role, he is responsible for managing relationships with health plans and PBMs and pharmacy organizations that partner with PQS to track quality measure performance. His role also includes analyzing performance data to develop insights, engagement approaches, and performance programs with network pharmacies, such as pharmacy pay-for-performance and other value-based payment strategies.

Session:
T-1 - Annual PQS Trend Report in Pharmacy Quality

Suzanne Schrandt, JD

CEO & Chief Patient Advocate

ExPPect

 

Suz Schrandt is a patient and patient engagement engineer, with a health and disability law and policy background. She launched ExPPect as a way to bring into focus the need for greater patient engagement across the healthcare ecosystem. Suz held roles in patient engagement leadership for the Patient-Centered Outcomes Research Institute, and the Arthritis Foundation, and has served for over 20 years as a patient instructor in pre and post graduate clinician education. She serves on the FDA’s Inaugural Patient Engagement Committee and is the Chair of the International Society for Pharmacoeconomic and Outcomes Research Global Patient Council. Suz is a frequently invited speaker at national and international conferences and has co-authored multiple publications on health policy and the importance of patient engagement.

Session:
FGS-3 - General Session: The Patient Perspective in Healthcare Quality

Todd Sorensen, PharmD

Professor and Associate Dean for Strategic Initiatives and Innovation

University of Minnesota College of Pharmacy

 

Dr. Sorensen is Professor and Associate Dean for Strategic Initiatives and Innovation at the University of Minnesota. He also serves as the Executive Director of the Alliance for Integrated Medication Management. He has 20 years of experience working with organizations to implement strategies that improve health outcomes associated with chronic illness, specifically relying on leadership strategies that allow organizations to integrate and sustain medication management services delivered by pharmacists. This work has been greatly influenced by diffusion of innovation theory, principles of quality improvement, the discipline of implementation science, and over ten years of experience participating in and leading national quality improvement collaboratives for health systems seeking to optimize medication use in outpatient settings.

Session:
W2-B1-A - Blending Pay-for-Performance and Implementation Science to Catalyze Medication Management Service Delivery, Improve Health and Produce Value

Samuel Stolpe, PharmD, MPH

Senior Director

National Quality Forum

 

Samuel Stolpe, PharmD, MPH joined NQF in October of 2018 serving as Senior Director, Quality Measurement. Trained as a pharmacist and epidemiologist, Dr. Stolpe’s career has been spent at the intersection of policy, public health, business, and healthcare quality. Dr. Stolpe served as the inaugural fellow at the National Association of Chain Drug Stores, working on issues related to patient-centered policy and research projects connecting emerging care models to community pharmacies. A deep interest in quality measurement led Dr. Stolpe to the Pharmacy Quality Alliance, where he managed PQA’s research and demonstration project portfolio, and led measure development focused on prevention and population health. Dr. Stolpe has also worked in healthcare technology, having served as the Vice President, Private Sector at Scientific Technologies Corporation, leading efforts to incorporate public health data assets into workflows for health plans, health systems, and community pharmacies. Dr. Stolpe has a doctor of pharmacy degree from Howard University and a master of public health degree from Harvard University.

Session:
IT-Q1A - Quality Measure Gaps in Opioid and Opioid Use Disorder

Vikram Sundararaman, PharmD, MBA

Clinical Pharmacy Site Manager

Genoa Healthcare

 

Vikram Sundararaman, PharmD, MBA is a Clinical Pharmacy Site Manager at Genoa Pharmacy in Hammond, IN. He manages one of the six Genoa Healthcare pharmacies within Oak Street Health clinics, and currently serves over 400 members on a monthly basis. His dedication to the consumers, clinic staff, and pharmacy team displays a level of enthusiasm and innovation that should be emulated in any community pharmacy practice. His efforts not only demonstrate outstanding performance in quality metric performance, but the Net Promoter Score (NPS) from his patients is unheard for a traditional community pharmacy. Dr. Sundararaman believes that a patient-centered approach and value-based service offerings are instrumental in advancing better outcomes in community pharmacy.

Session:
IT-CPIQ-1 - Community Pharmacy Innovation in Quality (CPIQ) Awards – Individual - Vikram Sundararaman, PharmD, MBA, Genoa Healthcare

Mike Umbleby, RPh

Vice President, Clinical Performance

Walgreens Co.

 

Mike is Vice President of Clinical Performance at Walgreens, leading a team responsible for setting the strategic direction for Walgreens clinical performance, medication adherence, enterprise business-to-business marketing and product innovation to support payer and plan sponsor partners.

Mike began his career at Walgreens in 1996 where he held various roles including pharmacy management and clinical oversight across several stores and regions. In 2008, Mike moved to Walgreens corporate headquarters and has held multiple leadership positions where he was responsible for launching enterprise-wide change initiatives across the organization, overseeing pharmacy innovation projects, and leading sales operations and client services for the Market Access sales and account management team.

Mike received his Bachelor of Science in Pharmacy from the University of Pittsburgh.

Session:
T4-B2-E - Turning Headwinds to Tailwinds: Leveraging Partnerships in a Rapidly Changing Environment to Deliver Omnichannel Programs that Deliver Higher Quality Ratings

Ben Urick, PharmD, PhD

Research Assistant Professor

UNC Eshelman School of Pharmacy

 

Ben Urick, PharmD, PhD, is an assistant professor at the Center for Medication Optimization in the Division of Practice Advancement and Clinical Education. His academic interests lie at the intersection of pharmacy practice, healthcare and health policy.

Dr. Urick’s primary research focuses on the role of community pharmacists in the evolving healthcare system and the use of secondary data to measure healthcare quality and spending. His current research includes evaluation of pharmacy services interventions, scientific reliability of provider-level quality measures, and factors which influence medication-related healthcare quality.

Session:
T2-B1-B - Exploring Drivers of Community Pharmacy-Level Performance on Adherence Measures

Yiqiao Zhang, MS

Graduate Research Assistant

University of Mississippi School of Pharmacy

 

Yiqiao Zhang is a doctoral candidate at the department of pharmacy administration, University of Mississippi. Her research interests include health economics and outcomes research, patient-reported outcomes, treatment patterns, and burden of illness. Currently, she is a graduate research assistant working on several grants in the area of diabetes, osteoporosis, mental health disorders, and stimulants use. Prior to working as a graduate research assistant, she was an analyst in the Mississippi Drug Utilization Review where she was responsible for conducting retrospective studies looking at clinical outcomes, healthcare resource utilization and costs, and medication adherence and persistence among Medicaid beneficiaries, in order to help inform Mississippi Medicaid policy decisions. She has published peer-reviewed manuscripts and has presented at several academic and international conferences.

Session:
F2-Q1-B - Quality Measurement in Screening and Management of Osteoporosis Among Older Adults